# Long-term Safety and Efficacy Extension Trial of Bimatoprost SR

> **NCT03891446** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **AbbVie** · enrollment: 455 (actual)

## Conditions studied

- Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Bimatoprost SR
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT03891446
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-27
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 455 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03891446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03891446, "Long-term Safety and Efficacy Extension Trial of Bimatoprost SR". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03891446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*